Summary
This report examines how biotechnology can improve public health and economic growth in Europe through better regulation and investment. 10 23.04.2026
Other
health
economy
science
education
environment
human rights
social policy
public administration
research and intellectual property
information technology and data processing
Key points
- Biotechnology is identified as a critical driver for Europe's health sovereignty and economic growth.
- A new 'EU Biotech Act' is proposed to simplify and harmonize the complex regulatory landscape across the Union.
- Clinical trials need to be made more efficient through better cross-border cooperation and faster approval timelines.
- Innovative solutions, such as bacteriophage therapy, are essential to combat the rising threat of antimicrobial resistance.
These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.